Can risk be predicted? An umbrella systematic review of current risk prediction models for cardiovascular diseases, diabetes and hypertension
Open accessThe DOI matches its Crossref record; 39 of the 41 references it cites were found in a registry or an index.
Abstract
Objective: To provide an overview of the currently available risk prediction models (RPMs) for cardiovascular diseases (CVDs), diabetes and hypertension, and to compare their effectiveness in proper recognition of patients at risk of developing these diseases. Design: Umbrella systematic review. Data sources: PubMed, Scopus, Cochrane Library. Eligibility criteria: Systematic reviews or meta-analysis examining and comparing performances of RPMs for CVDs, hypertension or diabetes in healthy adult (18–65 years old) population, published in English language. Data extraction and synthesis: Data were extracted according to the following parameters: number of studies included, intervention (RPMs applied/assessed), comparison, performance, validation and outcomes. A narrative synthesis was performed. Data were reported according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Study selection: 3612 studies were identified. After title/abstract screening and removal of duplicate articles, 37 studies met the eligibility criteria. After reading the full text, 13 were deemed relevant for inclusion. Three further papers from the reference lists of these articles were then added. Study appraisal: The methodological quality of the included studies was assessed using the AMSTAR tool. Risk of bias in individual studies: Risk of Bias evaluation was carried out using the ROBIS tool. Results: Sixteen studies met the inclusion criteria: six focused on diabetes, two on hypertension and eight on CVDs. Globally, prediction models for diabetes and hypertension showed no significant difference in effectiveness. Conversely, some promising differences among prediction tools were highlighted for CVDs. The Ankle-Brachial Index, in association with the Framingham tool, and QRISK scores provided some evidence of a certain superiority compared with Framingham alone. Limitations: Due to the significant heterogeneity of the studies, it was not possible to perform a meta-analysis. The electronic search was limited to studies in English and to three major international databases (MEDLINE/PubMed, Scopus and Cochrane Library), with additional works derived from the reference list of other studies; grey literature with unpublished documents was not included in the search. Furthermore, no assessment of potential adverse effects of RPMs was carried out. Conclusions: Consistent evidence is available only for CVD prediction: the Framingham score, alone or in combination with the Ankle-Brachial Index, and the QRISK score can be confirmed as the gold standard. Further efforts should not be concentrated on creating new scores, but rather on performing external validation of the existing ones, in particular on high-risk groups. Benefits could be further improved by supplementing existing models with information on lifestyle, personal habits, family and employment history, social network relationships, income and education. PROSPERO registration number: CRD42018088012.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Additional biomarkers, including apo B, lipoprotein(a), high-sensitivity C-reactive protein (CRP), coronary artery calcification score, and ankle-brachial index, are independent risk factors associated with increased risk of ASCVD events and may be helpful when the lipid management goal is unclear.”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [281]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & The PRISMA Group (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000097 · Cited by 64,042
Wang, G., Ma, R., Qiao, G., Wada, K., Aizawa, Y., & Satoh, T. (2015) · Integrative Medicine International · doi:10.1159/000368408 · Cited by 18,657
Forouzanfar, M. H., Afshin, A., Alexander, L. T., Anderson, H. R., Bhutta, Z. A., Biryukov, S., Brauer, M., Burnett, R., Cercy, K., Charlson, F. J., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31679-8 · Cited by 7,698
Social Relationships and Mortality Risk: A Meta-analytic Review
Holt-Lunstad, J., Smith, T. B., & Layton, J. B. (2010) · PLoS Medicine · doi:10.1371/journal.pmed.1000316 · Cited by 7,272
Economic Costs of Diabetes in the U.S. in 2002
American Diabetes Association (2003) · Diabetes Care · doi:10.2337/diacare.26.3.917 · Cited by 4,147
Mills, K. T., Bundy, J. D., Kelly, T. N., Reed, J. E., Kearney, P. M., Reynolds, K., Chen, J., & He, J. (2016) · Circulation · doi:10.1161/circulationaha.115.018912 · Cited by 3,531
Economic Costs of Diabetes in the U.S. in 2017
American Diabetes Association (2018) · Diabetes Care · doi:10.2337/dci18-0007 · Cited by 2,528
ROBIS: A new tool to assess risk of bias in systematic reviews was developed
Whiting, P., Savović, J., Higgins, J. P. T., Caldwell, D. M., Reeves, B. C., Shea, B., Davies, P., Kleijnen, J., & Churchill, R. (2016) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2015.06.005 · Cited by 2,272
Diabetes, Hypertension, and Cardiovascular Disease: Clinical Insights and Vascular Mechanisms
Petrie, J. R., Guzik, T. J., & Touyz, R. M. (2018) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2017.12.005 · Cited by 1,787
Prediction models for cardiovascular disease risk in the general population: systematic review
Damen, J. A. A. G., Hooft, L., Schuit, E., Debray, T. P. A., Collins, G. S., Tzoulaki, I., Lassale, C. M., Siontis, G. C. M., Chiocchia, V., Roberts, C., et al. (2016) · BMJ · doi:10.1136/bmj.i2416 · Cited by 935
Loef, M., & Walach, H. (2012) · Preventive Medicine · doi:10.1016/j.ypmed.2012.06.017 · Cited by 822
Risk models and scores for type 2 diabetes: systematic review
Noble, D., Mathur, R., Dent, T., Meads, C., & Greenhalgh, T. (2011) · BMJ · doi:10.1136/bmj.d7163 · Cited by 551
European Cardiovascular Disease Statistics 2017
Wilkins, E., Wilson, L. R., Wickramasinghe, K. K., Bhatnagar, P., Leal, J. L., Luengo-Fernández, R., Burns, R., Rayner, M., & Townsend, N. P. (2017) · Bristol Research (University of Bristol) · Cited by 516
Collins, G. S., Mallett, S., Omar, O., & Yu, L.-M. (2011) · BMC Medicine · doi:10.1186/1741-7015-9-103 · Cited by 484
Abbasi, A., Peelen, L. M., Corpeleijn, E., van der Schouw, Y. T., Stolk, R. P., Spijkerman, A. M. W., van der A, D. L., Moons, K. G. M., Navis, G., Bakker, S. J. L., et al. (2012) · BMJ · doi:10.1136/bmj.e5900 · Cited by 321
Trends in the epidemiology of cardiovascular disease in the UK
Bhatnagar, P., Wickramasinghe, K., Wilkins, E., & Townsend, N. (2016) · Heart · doi:10.1136/heartjnl-2016-309573 · Cited by 310
Comparisons of established risk prediction models for cardiovascular disease: systematic review
Siontis, G. C. M., Tzoulaki, I., Siontis, K. C., & Ioannidis, J. P. A. (2012) · BMJ · doi:10.1136/bmj.e3318 · Cited by 300
Assessment of Claims of Improved Prediction Beyond the Framingham Risk Score
Tzoulaki, I. (2009) · JAMA · doi:10.1001/jama.2009.1757 · Cited by 276
Pocock, S. J., McCormack, V., Gueyffier, F., Boutitie, F., Fagard, R. H., & Boissel, J.-P. (2001) · BMJ · doi:10.1136/bmj.323.7304.75 · Cited by 272
Damen, J. A., Pajouheshnia, R., Heus, P., Moons, K. G. M., Reitsma, J. B., Scholten, R. J. P. M., Hooft, L., & Debray, T. P. A. (2019) · BMC Medicine · doi:10.1186/s12916-019-1340-7 · Cited by 250
Risk Models to Predict Hypertension: A Systematic Review
Echouffo-Tcheugui, J. B., Batty, G. D., Kivimäki, M., & Kengne, A. P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0067370 · Cited by 152
Kontis, V., Mathers, C. D., Bonita, R., Stevens, G. A., Rehm, J., Shield, K. D., Riley, L. M., Poznyak, V., Jabbour, S., Garg, R. M., et al. (2015) · The Lancet Global Health · doi:10.1016/s2214-109x(15)00179-5 · Cited by 140
Collins, D. R. J., Tompson, A., Onakpoya, I., Roberts, N. W., Ward, A. M., & Heneghan, C. J. (2017) · BMJ Open · doi:10.1136/bmjopen-2016-013650 · Cited by 134
(2013) · PubMed · Cited by 116
Population Risk Prediction Models for Incident Heart Failure: A Systematic Review
Echouffo-Tcheugui, J. B., Greene, S. J., Papadimitriou, L., Zannad, F. M., Yancy, C. W., Gheorghiade, M., & Butler, J. (2015) · Circulation Heart Failure · doi:10.1161/circheartfailure.114.001896 · Cited by 108
Hypertension-related Mortality in the United States, 2000-2013.
Kung, H.-C., & Xu, J. (2015) · PubMed · Cited by 106
Recent development of risk-prediction models for incident hypertension: An updated systematic review
Sun, D., Liu, J., Xiao, L., Liu, Y., Wang, Z., Li, C., Jin, Y., Zhao, Q., & Wen, S. (2017) · PLOS ONE · doi:10.1371/journal.pone.0187240 · Cited by 87
Studziński, K., Tomasik, T., Krzysztoń, J., Jozwiak, J. J., & Windak, A. (2019) · BMC Cardiovascular Disorders · doi:10.1186/s12872-018-0990-2 · Cited by 75
Beswick, A. D., Brindle, P., Fahey, T. P., & Ebrahim, S. B. J. (2008) · PubMed · Cited by 69
10-Year Resource Utilization and Costs for Cardiovascular Care
Shaw, L. J., Goyal, A., Mehta, C. C., Xie, J. X., Phillips, L. M., Kelkar, A. A., Knapper, J. T., Berman, D. S., Nasir, K., Veledar, E., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.12.064 · Cited by 68
Gupta, R., Gupta, V. P., Prakash, H., Agrawal, A., Sharma, K. K., & DEEDWANIA, P. C. (2017) · Indian Heart Journal · doi:10.1016/j.ihj.2017.11.011 · Cited by 64
Risk assessment tools for detecting those with pre-diabetes: A systematic review
Barber, S. R., Davies, M. J., Khunti, K., & Gray, L. J. (2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2014.03.007 · Cited by 56
Cortés-Bergoderi, M., Thomas, R. J., Albuquerque, F. N., Batsis, J. A., Burdiat, G., Pérez-Terzic, C. M., Trejo-Gutiérrez, J. F., & López-Jiménez, F. A. (2012) · Revista Panamericana de Salud Pública · doi:10.1590/s1020-49892012000800007 · Cited by 41
Mehta, S., Ghosh, S., Sander, S. D., Kuti, E. L., & Mountford, W. K. (2018) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2018.24.3.280 · Cited by 41
Risk scoring for the primary prevention of cardiovascular disease
Beswick, A. D., Brindle, P. M., Ebrahim, S. B. J., & Fahey, T. P. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006887 · Cited by 27
Hu, P. L., Koh, Y. L. E., & Tan, N. C. (2016) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2016.10.019 · Cited by 26
Utility of nonblood-based risk assessment for predicting type 2 diabetes mellitus: A meta-analysis
Yoshizawa, S. M., Kodama, S., Fujihara, K., Ishiguro, H., Ishizawa, M., Matsubayashi, Y., Matsunaga, S., Yamada, T., Shimano, H., Kato, K., et al. (2016) · Preventive Medicine · doi:10.1016/j.ypmed.2016.07.026 · Cited by 3
Cited by
Blonde, L., Umpierrez, G. E., Reddy, S. S., McGill, J. B., Berga, S. L., Bush, M., Chandrasekaran, S., DeFronzo, R. A., Einhorn, D., Galindo, R. J., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.08.002 · Cited by 507
Stefan, N., & Schulze, M. B. (2023) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(23)00086-4 · Cited by 215
Digital Health in Primordial and Primary Stroke Prevention: A Systematic Review
Feigin, V. L., Owolabi, M. O., Hankey, G. J., Pandian, J. D., & Martins, S. C. O. (2022) · Stroke · doi:10.1161/strokeaha.121.036400 · Cited by 54
Mehta, S., Ghosh, S., Sander, S. D., Kuti, E. L., & Mountford, W. K. (2018) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2018.24.3.280 · Cited by 41
Sadoyu, S., Tanni, K. A., Punrum, N., Paengtrai, S., Kategaew, W., Promchit, N., Lai, N. M., Thakkinstian, A., Ngorsuraches, S., Bangpan, M., et al. (2022) · PLOS ONE · doi:10.1371/journal.pone.0269009 · Cited by 40
Metadata
- Authors
- Lucaroni, F., Cicciarella Modica, D., Macino, M., Palombi, L., Abbondanzieri, A., Agosti, G., Biondi, G., Morciano, L., & Vinci, A.
- Affiliations
- University of Rome Tor Vergata (IT)
- Biomedicine and Prevention, Università degli Studi di Roma Tor Vergata Facoltà di Medicina e Chirurgia, Roma, Lazio, Italy
- Corresponding author
- Palombi, Leonardo
- Venue
- BMJ Open
- Publisher
- BMJ
- Published
- 2019-12
- Volume
- 9
- Issue
- 12
- Pages
- e030234
- ISSN
- 2044-6055 (ISSN-L)
- PMC
- PMC6937066
- OpenAlex
- W2996239280
- Cited by
- 42
- References
- 41
- Citations by year
- 2026: 4 · 2025: 10 · 2024: 4 · 2023: 5 · 2022: 8 · 2021: 6 · 2020: 4
- FWCI
- 0.74
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc
- Locations
- BMJ Open (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Cineca Institutional Research Information System (Tor Vergata University) (submittedVersion, cc-by-nc-nd)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- HighWire Press Open Archive (submittedVersion)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Health Promotion and Cardiovascular Prevention
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Health Professions › Health Information Management › Artificial Intelligence in Healthcare
- Keywords
- risk prediction model, cardiovascular disease, diabetes mellitus, hypertension, Framingham risk score, ankle-brachial index, cardiovascular risk prediction, model validation, risk stratification, healthy adults, primary prevention of cardiovascular disease
- MeSH terms
- Cardiovascular Diseases, Diabetes Mellitus, Humans, Hypertension, Prognosis, Risk Factors, Reproducibility of Results, Models, Statistical, Risk Assessment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.


